1 - 15 of 204 Items

Invited Review Article2022, jan 5

Cannabis in Parkinson’s Disease — the patient’s perspective versus clinical trials: a systematic literature review

Monika Figura, Dariusz Koziorowski, Jarosław Sławek

Vol 56, No 1 (2022)

Invited Review Article

Pubmed: 34985112
Neurol Neurochir Pol 2022;56(1):21-27.
Invited Review Article2022, nov 29

Common therapeutic approaches in sleep and awake bruxism — an overview

Krystian Matusz, Zofia Maciejewska-Szaniec, Tomasz Gredes, Małgorzata Pobudek-Radzikowska, Mariusz Glapiński, Natalie Górna, Agnieszka Przystańska

Vol 56, No 6 (2022)

Invited Review Article

Pubmed: 36444852
Neurol Neurochir Pol 2022;56(6):455-463.
Research Paper2022, may 24

Effect of levetiracetam on nocturnal sleep in patients with epilepsy

Orlina Georgieva Chaneva, Ekaterina Ivanova Viteva

Vol 56, No 4 (2022)

Research Paper

Pubmed: 35607879
Neurol Neurochir Pol 2022;56(4):357-364.
Invited Review Article2022, feb 23

Use of cannabidiol in the treatment of epilepsy

Maria Mazurkiewicz-Bełdzińska, Marta Zawadzka

Vol 56, No 1 (2022)

Invited Review Article

Pubmed: 35211946
Neurol Neurochir Pol 2022;56(1):14-20.
Invited Review Article2022, feb 8

Cannabis and cannabinoids: pharmacology and therapeutic potential

Małgorzata Śmiarowska, Monika Białecka, Anna Machoy-Mokrzyńska

Vol 56, No 1 (2022)

Invited Review Article

Pubmed: 35133644
Neurol Neurochir Pol 2022;56(1):4-13.
Research Paper2022, may 24

Tower of London test — short version

Pavel Harsa, Michaela Břeňová, Ondřej Bezdíček, Lucie Kališová, Jana Heidingerová, Kateřina Schönová, Jiří Michalec

Vol 56, No 4 (2022)

Research Paper

Pubmed: 35607867
Neurol Neurochir Pol 2022;56(4):365-370.
Invited Review Article2022, jun 27

Update on pathology of central nervous system inflammatory demyelinating diseases

Alicja Kalinowska-Łyszczarz, Yong Guo, Claudia F. Lucchinetti

Vol 56, No 3 (2022)

Invited Review Article

Pubmed: 35758517
Neurol Neurochir Pol 2022;56(3):201-209.
Invited Review Article2022, jun 23

Immunosenescence and multiple sclerosis

Monika Adamczyk-Sowa, Maria Nowak-Kiczmer, Jerzy Jaroszewicz, Thomas Berger

Vol 56, No 3 (2022)

Invited Review Article

Pubmed: 35735245
Neurol Neurochir Pol 2022;56(3):220-227.
Invited Review Article2023, aug 22

Updates on pharmacological treatment for Alzheimer’s disease

Philip W. Tipton

Vol 58, No 2 (2024)

Invited Review Article

Pubmed: 37606550
Neurol Neurochir Pol 2024;58(2):150-160.
Review Article2023, feb 16

Impact of SARS-CoV-2 on the nervous system

Agata Czarnowska, Joanna Zajkowska, Alina Kułakowska

Vol 57, No 1 (2023)

Review Article

Pubmed: 36799524
Neurol Neurochir Pol 2023;57(1):26-35.
Review Article2023, feb 22

Blood-brain barrier function in response to SARS-CoV-2 and its spike protein

Łukasz Suprewicz, Krzysztof Fiedoruk, Agata Czarnowska, Marcin Sadowski, Agnieszka Strzelecka, Peter A. Galie, Paul A. Janmey, Alina Kułakowska, Robert Bucki

Vol 57, No 1 (2023)

Review Article

Pubmed: 36810757
Neurol Neurochir Pol 2023;57(1):14-25.
Review Article2023, feb 17

Hyperkinetic movement disorders following SARS-CoV-2 infection and vaccination — an update

Filip Przytuła, Jarosław Sławek

Vol 57, No 1 (2023)

Review Article

Pubmed: 36799521
Neurol Neurochir Pol 2023;57(1):63-76.
Research Paper2022, feb 4

Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus

Michalina Jasiak-Zatońska, Anna Pietrzak, Aleksandra Wyciszkiewicz, Ewa Więsik-Szewczyk, Katarzyna Pawlak-Buś, Piotr Leszczyński, Wojciech Kozubski, Sławomir Michalak, Alicja Kalinowska-Łyszczarz

Vol 56, No 3 (2022)

Research Paper

Pubmed: 35118639
Neurol Neurochir Pol 2022;56(3):246-255.
Review Article2022, jul 6

Is deep brain stimulation effective in Huntington’s Disease? — a systematic literature review

Justyna Kaczyńska, Emilia J. Sitek, Grzegorz Witkowski, Monika Rudzińska-Bar, Piotr Janik, Jarosław Sławek, Edeth Maria Garszia Edwin, Daniel Zielonka

Vol 56, No 4 (2022)

Review Article

Pubmed: 35792559
Neurol Neurochir Pol 2022;56(4):299-307.
Research Paper2022, jan 14

Relationship between blood-brain permeability and antibodies against aquaporins in neuromyelitis optica spectrum disorders and multiple sclerosis patients

Michalina Jasiak-Zatońska, Sławomir Michalak, Krystyna Osztynowicz, Wojciech Kozubski, Alicja Kalinowska-Łyszczarz

Vol 56, No 4 (2022)

Research Paper

Pubmed: 35029294
Neurol Neurochir Pol 2022;56(4):308-317.